These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 23242717)

  • 1. Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: a mono-institutional experience.
    Perri P; Fiorica F; D'Angelo S; Lamberti G; Parmeggiani F; Martini A; Carpenteri F; Colosimo C; Micucci M; Perazzini L; De Gugliemo E; Berretta M; Sebastiani A; Cartei F
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1919-24. PubMed ID: 23242717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
    Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
    Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ruthenium-106 plaque brachytherapy for uveal melanoma.
    Tarmann L; Wackernagel W; Avian A; Mayer C; Schneider M; Winkler P; Langmann G
    Br J Ophthalmol; 2015 Dec; 99(12):1644-9. PubMed ID: 25979763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease control and toxicity outcomes using ruthenium eye plaque brachytherapy in the treatment of uveal melanoma.
    Takiar V; Gombos DS; Mourtada F; Rechner LA; Lawyer AA; Morrison WH; Garden AS; Beadle BM
    Pract Radiat Oncol; 2014; 4(4):e189-94. PubMed ID: 25012839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes.
    Perez BA; Mettu P; Vajzovic L; Rivera D; Alkaissi A; Steffey BA; Cai J; Stinnett S; Dutton JJ; Buckley EG; Halperin E; Marks LB; Mruthyunjaya P; Kirsch DG
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):127-36. PubMed ID: 24613808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18 years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma.
    van Ginderdeuren R; van Limbergen E; Spileers W
    Br J Ophthalmol; 2005 Oct; 89(10):1306-10. PubMed ID: 16170122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy.
    Badiyan SN; Rao RC; Apicelli AJ; Acharya S; Verma V; Garsa AA; DeWees T; Speirs CK; Garcia-Ramirez J; Esthappan J; Grigsby PW; Harbour JW
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):801-5. PubMed ID: 24462385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat Episcleral Plaque Brachytherapy: Clinical Outcomes in Patients Treated for Locally Recurrent Posterior Uveal Melanoma.
    King B; Morales-Tirado VM; Wynn HG; Gao BT; Ballo MT; Wilson MW
    Am J Ophthalmol; 2017 Apr; 176():40-45. PubMed ID: 28048976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
    Toivonen P; Kivelä T
    Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results following episcleral ruthenium plaque radiotherapy for posterior uveal melanoma. The Swedish experience.
    Seregard S; aft Trampe E; Lax I; Kock E; Lundell G
    Acta Ophthalmol Scand; 1997 Feb; 75(1):11-6. PubMed ID: 9088393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
    Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vision Loss Following Episcleral Brachytherapy for Uveal Melanoma: Development of a Vision Prognostication Tool.
    Aziz HA; Singh N; Bena J; Wilkinson A; Singh AD
    JAMA Ophthalmol; 2016 Jun; 134(6):615-20. PubMed ID: 27101414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
    Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
    Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma.
    Lommatzsch PK; Werschnik C; Schuster E
    Graefes Arch Clin Exp Ophthalmol; 2000 Feb; 238(2):129-37. PubMed ID: 10766281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retina dose as a predictor for visual acuity loss in
    Heilemann G; Fetty L; Blaickner M; Nesvacil N; Zehetmayer M; Georg D; Dunavoelgyi R
    Radiother Oncol; 2018 Jun; 127(3):379-384. PubMed ID: 29452902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
    Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
    Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.